Results

Mitsubishi Tanabe Pharma Corporation

11/25/2019 | Press release | Distributed by Public on 11/24/2019 21:08

Mitsubishi Tanabe Pharma Announces the Start of a Phase 3 Clinical Trial using Oral Suspension of Edaravone for ALS